Edsivo Gets Breakthrough Therapy Status for Vascular Ehlers-Danlos Syndrome
The FDA has granted Breakthrough Therapy designation to Edsivo (celiprolol) for the treatment of patients with COL3A1-positive vEDS.
Stay updated with breaking news from Adrian Quartel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FDA has granted Breakthrough Therapy designation to Edsivo (celiprolol) for the treatment of patients with COL3A1-positive vEDS.
Industry veteran with over 20 years of drug development experience to oversee advancement of Acer’s product pipeline...
More OFF Time and Dyskinesia Education Needed, Survey Suggests Adamas Pharmaceuticals Inc launches the education campaign “Picture More Time” in response to a survey suggesting the need for education in the Parkinson’s community about OFF time and dyskinesia. An Incomplete Understanding The survey, co-sponsored by the Parkinson & Movement Disorder Alliance (PMD Alliance) and Adamas, received 775 respondents, including 527 people with PD and 248 care partners. Seventy-eight percent of those surveyed reported an incomplete understanding of OFF time and dyskinesia. The results also showed ...
FDA approves new indication for Adamas’ Gocovri in Parkinson’s disease Gocovri approved to treat patients with Parkinson’s disease experiencing OFF episodes The US Food and Drug Administration (FDA) has approved Adamas Pharmaceuticals’ Gocovri for a new indication in patients with Parkinson’s disease experiencing OFF episodes. The FDA has approved Gocovri (amantadine) as an adjunctive treatment to levodopa/carbidopa, a commonly-used treatment for the main symptoms of Parkinson’s disease. When Parkinson’s progresses, individuals receiving levodopa-based therapy often experience...
Piper Sandler Expands Investment Banking with the Hiring of Treavor Hill Piper Sandler Expands Investment Banking with the Hiring of Treavor Hill Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Treavor Hill as a managing director within the firms investment banking group. He will focus on the automotive and commercial vehicle aftermarkets and will be based in the firms Minneapolis office. Hill has over 10 years of investment banking experience focused on the aftermarket, executing both M&A advisory and growth/buyout financings. Prior t...